Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: Drug release and cytotoxicity against cancer cells

Ultrasonics

Volumn 49, Issue 1, 2009, Pages 39-46

  Fang, Jia You ^a   Hung, Chi Feng ^b   Hua, Shu Chiou ^a   Hwang, Tsong Long ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Camptothecin; Cancer; Drug delivery; Nanoemulsions; Perfluorocarbons

Indexed keywords

BLOOD; CONFOCAL MICROSCOPY; DRUG DELIVERY; EMULSIFICATION; INDUCTIVELY COUPLED PLASMA; LEAKAGE (FLUID); PHOSPHOLIPIDS; VEGETABLE OILS;

BROAD SPECTRUMS; CAMPTOTHECIN; CANCER; CANCER CELLS; CLINICAL APPLICATIONS; COCONUT OILS; CONFOCAL LASER SCANNING MICROSCOPIES; DELIVERY PROBLEMS; DROPLET DIAMETERS; DRUG DELIVERY CARRIERS; DRUG LOADINGS; DRUG RELEASES; INNER PHASE; NANOEMULSION; NANOEMULSIONS; OIL CONCENTRATIONS; OVARIAN CANCER CELLS; PERFLUOROCARBON; PERFLUOROCARBONS; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOL AMINES; PLURONIC; TOPOISOMERASE I;

BODY FLUIDS;

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG CARRIER; FLUOROCARBON;

APOPTOSIS; ARTICLE; CHEMISTRY; DRUG EFFECT; EMULSION; HUMAN; NEOPLASM; RADIATION EXPOSURE; TUMOR CELL CULTURE; ULTRASOUND;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; DRUG CARRIERS; EMULSIONS; FLUOROCARBONS; HUMANS; NEOPLASMS; SONICATION; TUMOR CELLS, CULTURED;

EID: 57049152398     PISSN: 0041624X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultras.2008.04.009     Document Type: Article

References (39)

1. Kawakami S., Yamashita F., and Hashida M. Deposition characteristics of emulsions and incorporated drugs after systemic or local injection. Adv. Drug. Deliv. Rev. 45 (2000) 77-88
2. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discover. 4 (2005) 145-160
3. Unger E.C., Porter T., Culp W., Labell R., Matsunaga T., and Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv. Drug Deliv. Rev. 56 (2004) 1291-1314
4. Miller A.P., and Nanda N.C. Contrast echocardiography: new agents. Ultrasound Med. Biol. 30 (2004) 425-434
5. Lum A.F.H., Borden M.A., Dayton P.A., Kruse D.E., Simon S.I., and Ferrara K.W. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J. Control. Release 111 (2006) 128-134
6. Koo O.M.Y., Rubinstein I., and Onyuksel H. Camptothecin in sterically stabilized phospholipid nano-micelles: a novel solvent pH change solubilization method. J. Nanosci. Nanotechnol. 6 (2006) 2996-3000
7. Hatefi A., and Amsden B. Camptothecin delivery methods. Pharm. Res. 19 (2002) 1389-1399
8. Thomas C.J., Rahier N.J., and Hecht S.M. Camptothecin: current perspectives. Bioorg. Med. Chem. 12 (2004) 1585-1604
9. Adams D.J. The impact of tumor physiology on camptothecin-based drug development. Curr. Med. Chem. Anti-Cancer Agent 5 (2005) 1-13
10. Hatefi A., Knight D., and Amsden B. A biodegradable injectable thermoplastic for localized camptothecin delivery. J. Pharm. Sci. 93 (2004) 1195-1204
11. Frenkel P.A., Chen S., Thai T., Shohet R.V., and Grayburn P.A. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. Biol. 28 (2002) 817-822
12. Liu Y., Miyoshi H., and Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J. Control. Release 114 (2006) 89-99
13. Herben V.M.M., ten Bokkel Huinink W.W., Schellens J.H.M., and Beijnen J.H. Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors. Pharm. World Sci. 20 (1998) 161-172
14. Li G., Bush J.A., and Ho V.C. p53-dependent apoptosis in melanoma cells after treatment with camptothecin. J. Invest. Dermatol. 114 (2000) 514-519
15. Vasir J.K., Reddy M.K., and Labhasetwar V.D. Nanosystems in drug-targeting: opportunities and challenges. Curr. Nanosci. 1 (2005) 47-64
16. Farhood H., Serbina N., and Huang L. The role of di-oleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235 (1995) 289-295
17. Litzinger D.C., and Huang L. Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim. Biophys. Acta 1113 (1992) 201-227
18. In: Vance D.E., and Vance J. (Eds). Biochemistry of Lipids, Lipoproteins and Membranes. fourth ed. (2002), Elsevier Publisher, Amsterdam
19. Klibanov A.L. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv. Drug Deliv. Rev. 37 (1999) 139-157
20. Fang J.Y., Hung C.F., Liao M.H., and Chien C.C. A study of the formulation design of lipid-coated microbubbles as carriers for drug delivery. Eur. J. Pharm. Biopharm. 67 (2007) 67-75
21. Jumaa M., and Müller B.W. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm. 163 (1998) 81-89
22. Ishii F., Sasaki I., and Ogata H. Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions. J. Pharm. Pharmacol. 42 (1990) 513-515
23. Pongcharoenkiat N., Narsimhan G., Lyons R.T., and Hem S.L. The effect of surface charge and partition coefficient on the chemical stability of solutes in o/w emulsions. J. Pharm. Sci. 91 (2002) 559-570
24. Daoud S.S., Fetouh M.I., and Giovanella B.C. Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts. Anti-Cancer Drug 6 (1995) 83-93
25. Yang S.C., Lu L.F., Cai Y., Zhu J.B., Liang B.W., and Yang C.Z. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control. Release 59 (1999) 299-307
26. Chang L.C., Lin C.Y., Kuo M.W., and Gau C.S. Interaction of pluronics with phospholipids monolayers at the air-water interface. J. Colloid Interf. Sci. 285 (2005) 640-652
27. von Corswant C., Thorén P., and Engström S. Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances. J. Pharm. Sci. 87 (1998) 200-208
28. Constandinides P.P., Lambert K.J., Tustian A.K., Schneider B., Lalji S., Ma W., Wentzel B., Kessler D., Worah D., and Quay S.C. Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel. Pharm. Res. 17 (2000) 175-182
29. Yoshioka T., and Florence A.T. Vesicle (noisome)-in-water-in-oil (v/w/o) emulsions: an in vitro study. Int. J. Pharm. 108 (1994) 117-123
30. Godin B., and Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J. Control. Release 94 (2004) 365-379
31. Lindner J.R., Song J., Xu F., Klibanov A.L., Singbartl K., Ley K., and Kaul S. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to active leukocytes. Circulation 102 (2000) 2745-2750
32. Benz C., Hollander C., Keniry M., James T.L., and Mitchell M. Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123. J. Clin. Invest. 79 (1987) 517-523
33. Agostinelli E., Belli F., Molinari A., Condello M., Palmigiani P., Vedova L.D., Marra M., Seiler N., and Arancia G. Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): sensitization by heat and MDL 72527. Biochim. Biophys. Acta-Mol. Cell Res. 1763 (2006) 1040-1050
34. Adams D.J., Dewhirst M.W., Flowers J.L., Gamcsik M.P., Colvin O.M., Manikumar G., Wani M.C., and Wall M.E. Camptothecin analogues with enhanced antitumor activity at acidic pH. Cancer Chemother. Pharmacol. 46 (2000) 263-271
35. Opanasopit P., Ngawhirunpat T., Chaidedgumjorn A., Rojanarata T., Apirakaramwong A., Phongying S., Choochottiros C., and Chirachanchai S. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system. Eur. J. Pharm. Biopharm. 64 (2006) 269-276
36. Kim T.W., Kim Y.J., Chung H., Kwon I.C., Sung H.C., and Jeong S.Y. The role of non-ionic surfactants on cationic lipid mediated gene transfer. J. Control Release 82 (2002) 455-465
37. Higashi N., Yamauchi M., Okumura Y., Nakanishi M., and Sunamoto J. Fusion between jurkat cell and PEO-lipid modified liposome. Biochim. Biophys. Acta 1285 (1996) 183-191
38. Unger E.C., Matsunaga T., McCreery T., Schumann P., Sweitzer R., and Quigley R. Therapeutic applications of microbubbles. Eur. J. Radiol. 42 (2002) 160-168
39. Lanza G.M., Wallace K.D., Scott M.J., Cacheris W.P., Abendschein D.R., Christy D.H., Sharkey A.M., Miller J.G., Gaffney P.J., and Wickline S.A. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 94 (1996) 3334-3340